The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis.
Christopher W RoweSam FaulknerJonathan W PaulJorge M TolosaCraig GedyeCino BendinelliKatie WynneShaun McGrathJohn AttiaRoger SmithHubert HondermarckPublished in: BMC endocrine disorders (2019)
ProNGF levels in serum and biopsy-rinse are not increased in thyroid cancer and therefore proNGF is not a clinical biomarker for this condition.